Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
An index fund aims to mirror a market index with low costs, while a mutual fund pools assets for active or diversified management.
28,655 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Apple is reportedly exploring a memory supplier in China to ease a chip shortage. Industry skeptics say the pivot won...
As Japan faces a shrinking workforce and aging digital infrastructure, devin-kun is emerging as a pivotal tool to mod...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
A 67-year-old homeowner with two mortgage-free homes worth millions weighs a HELOC to cover unexpected bills as rates...
NVIDIA earnings arrive with high volatility and big questions. This article breaks down the historical post-earnings ...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
CrowdStrike is set to report Q4 results after the close, with analysts predicting a beat on non-GAAP earnings and rev...
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
ARMLS moves to an independent board with an advisory council to keep practitioner voices in governance. The transitio...
The Goldman Sachs retirement survey shows a split: many workers feel they’re on track for retirement goals, but a maj...